{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:57:11Z","timestamp":1785891431420,"version":"3.56.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,4,15]]},"DOI":"10.1097\/01.tp.0000058515.02300.5e","type":"journal-article","created":{"date-parts":[[2003,12,2]],"date-time":"2003-12-02T06:40:08Z","timestamp":1070347208000},"page":"1061-1066","source":"Crossref","is-referenced-by-count":21,"title":["Liver transplantation followed by adjuvant nonmyeloablative hemopoietic stem cell transplantation for advanced primary liver cancer in humans1"],"prefix":"10.1097","volume":"75","author":[{"given":"Gunnar","family":"S\u00f6derdahl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisbeth","family":"Barkholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrik","family":"Hentschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Uzunel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-G\u00f6ran","family":"Ericzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olle","family":"Ringd\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-31-20210129","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1089-3261(05)70128-8","article-title":"The current status of liver transplantation for primary hepatic malignancy","volume":"4","author":"Suarez","year":"2000","journal-title":"Clin Liver Dis"},{"key":"R2-31-20210129","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/s-2007-1007120","article-title":"Liver transplantation for hepatocellular carcinoma","volume":"19","author":"Bismuth","year":"1999","journal-title":"Semin Liver Dis"},{"key":"R3-31-20210129","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"key":"R4-31-20210129","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00000658-199810000-00005","article-title":"Liver transplantation for hepatocellular carcinoma: A registry report of the impact of tumor characteristics on outcome","volume":"228","author":"Klintmalm","year":"1998","journal-title":"Ann Surg"},{"key":"R5-31-20210129","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1053\/jlts.2001.29419","article-title":"Liver transplantation for cholangiocellular carcinoma: Analysis of a single-center experience and review of the literature","volume":"7","author":"Shimoda","year":"2001","journal-title":"Liver Transpl"},{"key":"R6-31-20210129","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0168-8278(05)80250-8","article-title":"Liver transplantation for primary hepatocellular carcinoma: Tumor size and number determine outcome","volume":"18","author":"McPeake","year":"1993","journal-title":"J Hepatol"},{"key":"R7-31-20210129","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1056\/NEJM197905103001902","article-title":"Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts","volume":"300","author":"Weiden","year":"1979","journal-title":"N Engl J Med"},{"key":"R8-31-20210129","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood.V88.4.1501.bloodjournal8841501","article-title":"Evidence for a graft-versus-tumor effect in a patient treated with marrow ablative chemotherapy and allogeneic bone marrow transplantation for breast cancer","volume":"88","author":"Eibl","year":"1996","journal-title":"Blood"},{"key":"R9-31-20210129","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0140-6736(05)65517-1","article-title":"Graft-versus-tumour and graft-versus-leukaemia effect in patient with concurrent breast cancer and acute myelocytic leukaemia","volume":"348","author":"Ben-Yosef","year":"1996","journal-title":"Lancet"},{"key":"R10-31-20210129","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1200\/JCO.1998.16.3.986","article-title":"Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer","volume":"16","author":"Ueno","year":"1998","journal-title":"J Clin Oncol"},{"key":"R11-31-20210129","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1056\/NEJM200009143431101","article-title":"Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation","volume":"343","author":"Childs","year":"2000","journal-title":"N Engl J Med"},{"key":"R13-31-20210129","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/s-2008-1040632","article-title":"Refinements in the surgical technique of liver transplantation","volume":"5","author":"Starzl","year":"1985","journal-title":"Semin Liver Dis"},{"key":"R14-31-20210129","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1053\/bbmt.2001.v7.pm11215696","article-title":"The role of disease stage in the response to donor lymphocyte infusions as treatment for leukemic relapse","volume":"7","author":"Carlens","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"R15-31-20210129","first-page":"619","article-title":"Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings","volume":"15","author":"Ringden","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"R16-31-20210129","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1399-0039.1992.tb01940.x","article-title":"HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation","volume":"39","author":"Olerup","year":"1992","journal-title":"Tissue Antigens"},{"key":"R17-31-20210129","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1182\/blood.V94.2.455","article-title":"Peripheral blood stem cell transplantation from unrelated donors: A comparison with marrow transplantation","volume":"94","author":"Ringden","year":"1999","journal-title":"Blood"},{"key":"R18-31-20210129","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.leu.2401669","article-title":"Minimal residual disease is common after allogeneic stem cell transplantation in patients with B cell chronic lymphocytic leukemia and may be controlled by graft-versus-host disease","volume":"14","author":"Mattsson","year":"2000","journal-title":"Leukemia"},{"key":"R19-31-20210129","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/sj.bmt.1702337","article-title":"Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia","volume":"25","author":"Zetterquist","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"R20-31-20210129","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"key":"R21-31-20210129","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/PL00009948","article-title":"Role of adjuvant treatment in liver transplantation for advanced hepatocellular carcinoma","volume":"5","author":"Cherqui","year":"1998","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"R22-31-20210129","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1097\/00007890-200005270-00012","article-title":"Transplantation of autologous and allogeneic bone marrow with liver from a cadaveric donor for primary liver cancer","volume":"69","author":"Ringden","year":"2000","journal-title":"Transplantation"},{"key":"R23-31-20210129","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","article-title":"Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases","volume":"91","author":"Slavin","year":"1998","journal-title":"Blood"},{"key":"R24-31-20210129","first-page":"191","article-title":"Migratory nonparenchymal cells after organ allotransplantation: With particular reference to chimerism and the liver","volume":"12","author":"Starzl","year":"1994","journal-title":"Prog Liver Dis"},{"key":"R25-31-20210129","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1097\/00007890-199905270-00011","article-title":"Role of donor leukocyte chimerism in establishing the etiology of neutropenia after liver transplantation","volume":"67","author":"Jonsson","year":"1999","journal-title":"Transplantation"},{"key":"R26-31-20210129","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0167-5699(96)10070-0","article-title":"The lost chord: Microchimerism and allograft survival","volume":"17","author":"Starzl","year":"1996","journal-title":"Immunol Today"},{"key":"R27-31-20210129","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1053\/jhep.2000.9124","article-title":"Liver from bone marrow in humans","volume":"32","author":"Theise","year":"2000","journal-title":"Hepatology"},{"key":"R28-31-20210129","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reaction following bone marrow transplantation in humans","volume":"75","author":"Horowitz","year":"1989","journal-title":"Blood"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.TP.0000058515.02300.5E","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T18:54:33Z","timestamp":1785783273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-200304150-00031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4,15]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2003]]}},"URL":"https:\/\/doi.org\/10.1097\/01.tp.0000058515.02300.5e","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2003,4,15]]}}}